chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous report was received from a pharmacist referring to a male patient of unknown age. The patient had not concurrent conditions, medical history, concomitant medications, drug reactions or allergies. On 02-OCT-2017, the patient was vaccinated with PNEUMOVAX 23 (strength, dose or anatomical location were not reported) lot #N019983, expiration date on 03-MAR-2019, by intramuscular route for prophylaxis (reported as vaccine). On an unspecified date in October 2017 (7 hours after the vaccination), the patient experienced swollen and tender arm which was slightly warm and the arm had limited movement. The primary reporter stated that the patient notified the Pharmacist on unspecified date. Also, ice packs and Acetaminophen were given, which helped and at the time of reporting the patient's arm was less swollen and tender. No laboratory tests were performed and no additional information was provided. The action taken with the suspect therapy was not applicable. At the time of reporting the patient was recovering from the events. The causal relationship between the events and the suspect therapy was not provided.
Loss of taste and mild numbness on right side of the tongue.  Noticed it the morning after my first dose of vaccine.  After I brushed my teeth, I proceeded to brush my tongue and could not feel the right side.  weird sensation like when the anesthesia is starting to wear off after a dental procedure.  Later that morning, I couldn't taste a cinnamon gum i put in my mouth, except on the left side.  Anything I eat, I cannot taste it on my right side.  Only on the left side.  Neither the taste or feeling has returned to this date (5/18/21 - almost two months)
Menstruation started after not having a period for 4 months. Started again may 25 and is still continuing
increase in fatigue; confusion/dizziness; confusion/dizziness; lethargy; flushed; brain fog; soreness on injection site; fatigue; This is a spontaneous report from a contactable consumer. A 29-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection),via an unspecified route of administration, administered in Arm Left on 06Mar2021 10:45 (Age at vaccination 29 years old) (Batch/Lot Number: Unknown) as Dose 1,Single for covid-19 immunization. Medical history included polycythaemia vera, hiv infection from an unknown date and unknown if ongoing. Prior to vaccination, the patient was not diagnosed with COVID-19 and Since the vaccination, the patient has not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Concomitant medications included bictegravir sodium, emtricitabine, tenofovir alafenamide fumarate (BIKTARVY) taken within 2 weeks of vaccination.On 06Mar2021 at 15:00, the patient experienced fatigue, on 07Mar2021 at 15:00 soreness on injection site, on 08Mar2021 at 15:00 lethargy, flushed brain fog, on 09Mar2021 at 15:00 increase in fatigue confusion/dizziness. Outcome of events was not recovered. Information on the lot/batch number has been requested.
I had shingles and was treated with valacyclovir. It was a mild case. I had already gotten one shingle shot. It resolved in 1-2 weeks.
This spontaneous report as received from a other health professional refers to a 17 days old patient. The patient was vaccinated with the first, second, third and fourth dose of RECOMBIVAX HB (dose, route and lot number not provided) respectively on 28-JUL-1997, 11-AUG-1997, 24-SEP-1997 and 09-FEB-1998. No other co-suspects were reported. No concomitant medications were reported. No adverse effect reported. Additional information has been requested.
in less than 5 minutes rt upper arm swollen, welt, red & body rash macular erythema-confluent;
Pt c/o facial numbness & limited cheek movement. Diagnosed with Bell's Palsy 9/1/10.
first dose 2 years ago, should they repeat the dosing; This case was reported by a consumer and described the occurrence of incomplete course of vaccination in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received 2 years ago from the date of reporting).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were reported as follows: The age at vaccination was not applicable. The patient did not receive the 2nd dose till the time of reporting, which led to incomplete course of vaccination. The reporter asked should they repeat the dosing to get 2 doses again. No contact details were available.
A 78 year old female reported she received an injection of '00-'01 of influenza virus vaccine on 11/7/00. Subsequently, she experienced dizziness, headache, insomnia and bone aches. The caller stated that her physician found no evidence of infection.
Patient developed round warm raised area at the area that the varicella vaccine was given 50 x 40 mm area. Was put on antibiotics.
The employee stated she had swollen, painful lymph nodes located on her left neck/collarbone area.
Patient felt fine when she was at the doctor's office. After receiving the shot, patient went home and started to feel dizzy, nauseous and her shoulder was sore. Patient called in the next day and talked to nurses. Was in bed for two days with 102 temperature and not feeling well at all. Horrible cough to the point where she would wretch and her head hurt.  Still has on Jan 20th but not as bad.
The patient came in for the booster Pfizer, however, due to miscommunication, mom requested a Moderna booster (not knowing it is not available/approved for patient's age). The staff took the patient over to the Moderna line. The vaccinator did not confirm if the patient/parent was not aware of what type of booster could be given to the patient. The vaccinator gave the patient a Moderna booster (.25mL).
No other adverse event; Received the first dose on 09-SEP-2021 and second dose on 05-OCT-2021; Patient received first dose of M-M-R II vaccine at 36 years of age; This spontaneous report was received from a registered nurse, and refers to a 36 year old patient. The patient's pertinent medical history, drug reactions, allergies, and concomitant medications were not provided.  On 09-SEP-2021, the patient was vaccinated with the first dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live(M-M-R II) and dose 2 was administered on 05-OCT-2021 (Inappropriate schedule of product administration) as prophylaxis (lot#, expiration date, dose, anatomical location and route of administration were not provided).  On 09-SEP-2021, the patient received the first dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live(M-M-R II) at 36 years of age (Product administered to patient of inappropriate age). No other adverse event occurred and no further information provided.
Hives on my face and body with0in hours of getting the vaccine. Along with other normal symptoms like fever, stomach pain, and diarrhea.
Flu shot -hives started after 3 hours. by 1230am itchy and swollen;  hives on my left arm-vaccination site
Woke up and was barely able to walk.  Legs felt like they had wieghts on them - like gravity was heavy. Any walking caused pain.   Called doctor on 12/24/12 who suggested going to emergency room.  Received MRI at hospital and was recommended to see neurogist, and pain specialist.  Went to both and then saw neurosurgeon who sent me back to neurologist for lumbar puncture.  Results of lumbar puncture came back on 1/7 diagnosing Guillain-Barre and was admitted to hospital for 6 days and given IVIG treatment for 5 days.  Still unable to walk for more than a few feet unassisted.  Pain persists.
Mother in with child complains of swelling to left arm, no temp, no itching, no redness. Noted edema. 5 cms in measurement. Child received immunizations in the AM of  3/19/04. Cold compress applied to site Benadryl given to
no adverse effects reported; Second M-M-R II was given too early; Patient is late receiving his vaccines/ received his first dose of M-M-R II on 20-MAR-2019; This spontaneous report was received from a medical assistant, referring to a 7 years-old male patient. The patient's relevant medical history, previous drug reactions or allergies, concomitant medications, and concurrent conditions were not reported.  The reporter stated that the patient was receiving his vaccines late; because, on 20-MAR-2019, the patient was vaccinated with the first dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) (product administered to patient of inappropriate age) for prophylaxis (strength, dose, frequency, route of administration, anatomical site of injection, lot # and expiration date were not reported).  It was reported that after receiving the first dose, an appointment was scheduled for a month later, to administer the second dose of the vaccine; but this appointment was "moved up" and the second dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) was administered too early (inappropriate schedule of product administration).  On 02-APR-2019, the patient received the second dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) for prophylaxis (strength, dose, frequency, route of administration, anatomical site of injection, lot # and expiration date were not reported).   By the time of this report, no adverse effects were reported.
Syncope  190    p 2nd Covid vaccine (Pfizer). Sy Resolved .
This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a female patient (pt) of unknown age. No information was provided regarding medical history, concurrent conditions, or concomitant medications. On 31-MAY-2016, the patient was vaccinated with ZOSTAVAX (lot#, expiration date, dose, dose# and route not specified) at a pharmacy for the prevention of shingle. In approximately 2016 (reported as shortly after the vaccination), pt suffered and was later diagnosed with shingles on the left side of her upper back area. Pt also suffered and was diagnosed with dry eye syndrome and pneumonia. The pt claimed that the vaccine did not prevent shingles, but rather caused contract persistent strain of herpes zoster, dry eye syndrome and pneumonia. As a direct and proximate result of defective vaccine, pt suffered painful injuries and damages, and required extensive medical care and treatment. Pt sustained severe and permanent personal injuries. Further, pt suffered serious, progressive, permanent, and incurable injuries, as well as significant conscious pain and suffering, mental anguish, emotional distress, loss of enjoyment of life, physical impairment and injury. The outcome of pneumonia, herpes zoster, vaccination failure and dry eye syndrome was unknown. The reporter considered all events to be related to ZOSTAVAX. The events pneumonia, herpes zoster, vaccination failure and dry eye syndrome were considered to be disability. Upon internal review, pneumonia was determined to be medically significant. The event of pneumonia, herpes zoster, vaccination failure and dry eye were considered disabling. Additional information has been requested.
Child became lethargic a few hours after the shot, then later that evening developed a fever and had no interest in nursing. 24 hours later he started screaming and would not stop for 12 hours. Took to ER.
I've been sad, feeling depressed, nauseous and I burst out crying for no reason at all!
This spontaneous report as received from a pharmacist (also reported as non-healthcare professional) refers to a 62 year old female patient. On 09-APR-2014 the patient was vaccinated with a dose of ZOSTAVAX lot # J012660, expiry date 10-JAN-2015, once, in the left arm (dose and route not reported). The patient's relevant concomitant medication and past drug history were unknown. The patient had no history of injection site reactions. On 09-APR-2014 (also reported as on an unknown date, following the injection), the patient experienced golf-ball sized area at the injection site that is red and crusty and arm itches from the elbow to the armpit. It was unknown if there was relevant laboratory data. It was unknown if the patient would receive another injection of ZOSTAVAX. At the time of the report, the patient continued to experience golf-ball sized area at the injection site that is red and crusty and arm itching from the elbow to the armpit. Additional information has been requested.
I began to experience lightheadedness, generalized weakness and confusion. My handwriting changed. These faded over the afternoon only to recur at the same time next morning, resolving in the afternoon once again. I was afraid i was having a heart attack and called 911 and was taken to Hospital where I ruled out for an MI. In the ambulance i received four baby aspirin. I was discharged that night. The next morning, i  developed poor balance and fell twice while walking. Weakness also recurred with confusion. I could not stand myself up. I went to another Hospital and spent the night in Observation. The next morning no symptoms occurred but I refrained from walking as much as possible that day. At hospital I received IV fluid and my usual medications. Neurology consultation revealed possibly abnormal reflexes and poor balance. I received a cane from physical therapy. Since then symptoms have mostly not resolved but weakness and falls have recurred. Evaluation for fall and poor balance continues to date. I received the second dose of the Moderna immunization as scheduled without incident.
Hotness; Pain in the lower back; Body aches; chills; headache; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 02-Jun-2021 and was forwarded to Moderna on 02-Jun-2021.    This spontaneous case was reported by a consumer and describes the occurrence of FEELING HOT (Hotness), BACK PAIN (Pain in the lower back), MYALGIA (Body aches), CHILLS (chills) and HEADACHE (headache) in a 39-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced FEELING HOT (Hotness), BACK PAIN (Pain in the lower back), MYALGIA (Body aches), CHILLS (chills) and HEADACHE (headache). At the time of the report, FEELING HOT (Hotness), BACK PAIN (Pain in the lower back), MYALGIA (Body aches), CHILLS (chills) and HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient thinks that pain is due to effort  made in lifting chair.  No Treatment and concomitant medicines were reported
patient experienced numbness, tingling and "burning" sensation in left arm several minutes after receiving 1st dose of Moderna Covid-19 vaccine
Syncope, nauseous. Patient laid out for 15 minutes, felt better with juice and ice pack.
Tested positive for COVID; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Tested positive for COVID) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no reported medical history).    On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Jan-2021, the patient experienced COVID-19 (Tested positive for COVID). At the time of the report, COVID-19 (Tested positive for COVID) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter. No treatment information was provided.
sick; Pain in arm; Abnormal breathing; swollen throat; Pain/ Ache; dizziness; Muscle pain; Fever; Nausea; Vomiting; Chills; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of ILLNESS (sick), PAIN IN EXTREMITY (Pain in arm), RESPIRATION ABNORMAL (Abnormal breathing), PHARYNGEAL SWELLING (swollen throat) and PAIN (Pain/ Ache) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 24-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) at an unspecified dose. On 21-Apr-2021, the patient experienced ILLNESS (sick), PAIN IN EXTREMITY (Pain in arm), RESPIRATION ABNORMAL (Abnormal breathing), PHARYNGEAL SWELLING (swollen throat), PAIN (Pain/ Ache), DIZZINESS (dizziness), MYALGIA (Muscle pain), PYREXIA (Fever), NAUSEA (Nausea), VOMITING (Vomiting) and CHILLS (Chills). At the time of the report, ILLNESS (sick), PAIN IN EXTREMITY (Pain in arm), RESPIRATION ABNORMAL (Abnormal breathing), PHARYNGEAL SWELLING (swollen throat), PAIN (Pain/ Ache), DIZZINESS (dizziness), MYALGIA (Muscle pain), PYREXIA (Fever), NAUSEA (Nausea), VOMITING (Vomiting) and CHILLS (Chills) outcome was unknown. Unknown          This case was linked to MOD-2021-085700, MOD-2021-085700 (Patient Link).
flu like symptoms; ear drums burning; ear drums burning; This case was reported by a consumer via call center representative and described the occurrence of influenza-like symptoms in a 19-year-old male patient who received Men B NVS (Bexsero) for prophylaxis.   Co-suspect products included meningococcal B vaccine (Trumenba) for prophylaxis.   In June 2019, the patient received the 2nd dose of Bexsero (intramuscular). On an unknown date, the patient started Trumenba at an unknown dose and frequency. In June 2019, several hours after receiving Bexsero, the patient experienced influenza-like symptoms, tympanic membrane inflammation and interchange of vaccine products. On an unknown date, the outcome of the influenza-like symptoms and tympanic membrane inflammation were recovered/resolved and the outcome of the interchange of vaccine products was unknown.   It was unknown if the reporter considered the influenza-like symptoms and tympanic membrane inflammation to be related to Bexsero.  Additional details were provided as follows: This case was reported by the patient's mother. In December 2018, the patient received 1st dose of Trumenba and in June 2019, the patient received 2nd dose of Bexsero, which led to interchange of vaccine products. The patient experienced flu like symptoms and ear drums burning the evening after the dose was given and that those symptoms were resolved in about 24 hours. The reporter consented to follow up.
Patient presented to emergency department on 8/25/2021 following a fall at his assisted living facility. During admission, was tested for COVID-19 and found to be positive on 9/2/2021. Patient was discharged on 9/15/2021 back to facility with hospice services.
Extreme dizziness when turn head from side-to-side.  Ears feel that they are full and pulsing, no pain.  Never had ear problems prior, not sick.   Went to emergency room and had CAT scan and blood work.  All normal.   Doctor prescribed Meclizine.   Patient did exercises to try to move ear crystals back into place.   Recovered to 90% within 24hrs.  Still experiencing some dizziness as of filing Jan 6th but not to the same extent.  Ears still feel full.
3 year old child given PEDIARIX for 4th DTaP dose. Intended to administer INFANRIX. Also administered HepB and IPV separately.
First two days was same as the first shot - fatigue, temperature, etc..  The 3rd day after the 2nd vaccination, I broke out in hives and now I am in day 5 after the vaccine with hives all over my body and have to take steroids and additional antihistamines.
4-5 hrs after vaccination pt w/ extreme pallor/listlesness; alternating periods betw. sleeping and screaming.  child's color was "dead-baby white" per mother.  (very reliable parents).  also had temp of 99.1 but was given tylenol 2 hrs before event.  overall, consistent w/ hypotonic-hyporesponsive episode.
April 30, 2022 I felt like I was a little congested like I had the start of a sinus infection.  I woke up on April 31, 2022 with more sinus pressure thought I had the start of a sinus infection. I woke up around 1am on May 1, 2022 with low grade fever around 99.0 and a sore throat. Fever continued throughout the day so I decided to take a home test and it was positive. Fever did run 99.0-100.0 on and off, sinus pressure was still there, get winded very easily and the sore throat was worse.  Called my doctor on Tuesday and she prescribed Paxlovid. Wednesday I started medication and noticed a little difference within 6 hours.  Symptoms did gradually get better. Now I do feel very fatigued and have a dry cough.
Began with psoriatic arthritis on both elbows, forearms and knees.  Was treated with steroid cream.  At this time  I also started experiencing swelling in both wrists and hands and extreme pain and weakness.  Body chills and aches.  Went to Arthritis Center in early January 2022.
Severe Headache on 1/12/21 at 7:45 pm. Woke up with extreme muscle aches 1/13/21 at 5:30 AM. Pins and Needles sensation started at 1/13/21 at 6:20 AM. Fever of 101.9 (oral) noticed at 10:30 AM.
Confusion and speech difficulty.  Admitted to local ER.  Transferred to larger hospital for additional tests.  Ruled out stroke, seizure, infection, or brain tumor.   Discharged after two days.  Prescribed meds for anxiety and blood pressure.  Recovered after missing a week of work.
Pain on arm; Dizziness/feel light headed; Tingling on face; Tingling on lips; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (Tingling on face), PARAESTHESIA ORAL (Tingling on lips), PAIN IN EXTREMITY (Pain on arm) and DIZZINESS (Dizziness/feel light headed) in a 37-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011220a) for COVID-19 vaccination.     No Medical History information was reported.    On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Jan-2021, the patient experienced PARAESTHESIA (Tingling on face), PARAESTHESIA ORAL (Tingling on lips) and DIZZINESS (Dizziness/feel light headed). On 15-Jan-2021, the patient experienced PAIN IN EXTREMITY (Pain on arm). At the time of the report, PARAESTHESIA (Tingling on face), PARAESTHESIA ORAL (Tingling on lips), PAIN IN EXTREMITY (Pain on arm) and DIZZINESS (Dizziness/feel light headed) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported. No treatment related information has been reported.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events a causal relationship cannot be excluded.
Patient felt like lump in throat, given benadryl at 15 minutes post administration. Patient continued to have swelling feeling. Brought to procedure room in clinic and given epinephrine 0.3 mg. Vitals monitored and patient sent via ambulance to hospital for further monitoring
Pt had 2 doses of Pfizer Covid 19 vaccine.  Ist 11/13/2021, 2nd dose 12/4/2021 at Medical Group. Pt had mild covid symptoms on 12/24/21, tested positive 12/24/2021. 1/30/2022 pt had fever 103.5 2/1 dev rash, chest tightness, abd pain and diarrhea. chest tightness and GI symptoms resolved, however rash spread, developed conjunctival injection, Cervical LAD and polymorphous rash.  pt admitted 2/5/2022 and diagnosed with MIS-C.  (mild)